OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Dr. Watkins has an extensive background in vaccine research using the Indian rhesus macaque to test vaccine concepts. He has conducted more than 10 vaccine trials in Indian rhesus macaques using a variety of regimens and challenge models. His main interests lie in finding T cell and antibody-based vaccines for several pathogens. He has worked with Brazilian collaborators both at FIOCRUZ and at the University of São Paulo for the last several years and has co-authored multiple publications with them. More recently his laboratory has developed a facility in culturing and measuring viral concentrations and immune responses against flaviviruses as a direct result of the use of recombinant YF17D as a vaccine vector. Dr. Watkins’ extensive experience in testing vaccine approaches in NHP gives him the necessary background to develop vaccine for HTLV-1.
